Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A systematic review of substandard, falsified, unlicensed and unregistered medicine sampling studies: a focus on context, prevalence, and quality
Dominic McManus, Bernard Naughton
BMJ Global Health (2020) Vol. 5, Iss. 8, pp. e002393-e002393
Open Access | Times Cited: 59

Showing 1-25 of 59 citing articles:

Methicillin Resistant Staphylococcus aureus: Molecular Mechanisms Underlying Drug Resistance Development and Novel Strategies to Combat
Assefa Abebe, Birhanu Alemayehu
Infection and Drug Resistance (2023) Vol. Volume 16, pp. 7641-7662
Open Access | Times Cited: 45
Substandard and falsified antibiotics: neglected drivers of antimicrobial resistance?
Guillermo A Zabala, Khonsavath Bellingham, Vayouly Vidhamaly, et al.
BMJ Global Health (2022) Vol. 7, Iss. 8, pp. e008587-e008587
Open Access | Times Cited: 46
Substandard and falsified antimicrobials in selected east African countries: A systematic review
Addisu Afrassa Tegegne, Anbessa Bekele Feissa, Gemmechu Hasen, et al.
PLoS ONE (2024) Vol. 19, Iss. 1, pp. e0295956-e0295956
Open Access | Times Cited: 11
Substandard and falsified medical products: bibliometric analysis and mapping of scientific research
Waleed M. Sweileh
Globalization and Health (2021) Vol. 17, Iss. 1
Open Access | Times Cited: 50
The Impact of Climate Change on Health Services in Low- and Middle-Income Countries: A Systematised Review and Thematic Analysis
Kamar Naser, Zaeem Haq, Bernard Naughton
International Journal of Environmental Research and Public Health (2024) Vol. 21, Iss. 4, pp. 434-434
Open Access | Times Cited: 7
Prevalence of substandard, falsified, unlicensed and unregistered medicine and its associated factors in Africa: a systematic review
Biset Asrade Mekonnen, Muluabay Getie Yizengaw, Minichil Worku
Journal of Pharmaceutical Policy and Practice (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 5
Characterizing Medicine Quality by Active Pharmaceutical Ingredient Levels: A Systematic Review and Meta-Analysis across Low- and Middle-Income Countries
Sachiko Ozawa, Hui-Han Chen, Yi‐Fang Lee, et al.
American Journal of Tropical Medicine and Hygiene (2022) Vol. 106, Iss. 6, pp. 1778-1790
Open Access | Times Cited: 22
Digital intervention to reduce counterfeit and falsified medicines: A systematic review and future research agenda
Iyolita Islam, Muhammad Nazrul Islam
Journal of King Saud University - Computer and Information Sciences (2022) Vol. 34, Iss. 9, pp. 6699-6718
Closed Access | Times Cited: 20
Impact of the COVID-19 pandemic on pharmacy practice and on the provision of pharmaceutical care: A cross-sectional study among community pharmacists
Georges Hatem, Sara Ghamloush, Aya Al Chami, et al.
The Journal of Medicine Access (2023) Vol. 7
Open Access | Times Cited: 13
Analysis of pharmacovigilance databases for spontaneous reports of adverse drug reactions related to substandard and falsified medical products: A descriptive study
Kevin Pozsgai, Gergő Szűcs, Anikó Kőnig-Péter, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 19
Understanding the regulatory-procurement interface for medicines in Africa via publicly available information on standards, implementation, and enforcement in five countries
Jillian C. Kohler, Mariangela Castro-Arteaga, Saher Panjwani, et al.
Journal of Pharmaceutical Policy and Practice (2025) Vol. 18, Iss. 1
Open Access
Patient‐driven personal importation in the face of cost barriers to care: can we do better?
Narcyz Ghinea, Hazel Heal, Mark Danta
Internal Medicine Journal (2025) Vol. 55, Iss. 1, pp. 130-133
Closed Access
Substandard antibiotics and their clinical outcomes among hospitalized patients in southern Malawi: a pilot study
Francis Kachidza Chiumia, Adamson S. Muula, Frider Chimimba, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Current access, availability and use of antibiotics in primary care among key low- and middle-income countries and the policy implications
Zikria Saleem, Biset Asrade Mekonnen, E Sam Orubu, et al.
Expert Review of Anti-infective Therapy (2025)
Open Access
Patients Access to Medicines – A Critical Review of the Healthcare System in Kenya
Anthony Martin Toroitich, Louise Dunford, Rachel Armitage, et al.
Risk Management and Healthcare Policy (2022) Vol. Volume 15, pp. 361-374
Open Access | Times Cited: 16
Quality of Essential Medicines from Different Sources in Enugu and Anambra, Nigeria
Julia Gabel, Micha Lächele, Katharina Sander, et al.
American Journal of Tropical Medicine and Hygiene (2024) Vol. 111, Iss. 1, pp. 179-195
Open Access | Times Cited: 3
Excessive active pharmaceutical ingredients in substandard and falsified drugs should also raise concerns in low-income countries
Elisa M. Maffioli, Marie C Montás, Chimezie Anyakora
Journal of Global Health (2024) Vol. 14
Open Access | Times Cited: 3
Substandard and Falsified Medicines: Proposed Methods for Case Finding and Sentinel Surveillance
Elizabeth Pisani, Amalia Hasnida, Mawaddati Rahmi, et al.
JMIR Public Health and Surveillance (2021) Vol. 7, Iss. 8, pp. e29309-e29309
Open Access | Times Cited: 20
Identification of Substandard and Falsified Medicines: Influence of Different Tolerance Limits and Use of Authenticity Inquiries
Cathrin Hauk, Nhomsai Hagen, Lutz Heide
American Journal of Tropical Medicine and Hygiene (2021) Vol. 104, Iss. 5, pp. 1936-1945
Open Access | Times Cited: 19
Blockchain for Data Originality in Pharma Manufacturing
Marta Durá, Fátima Leal, Ángel Sánchez-García, et al.
Journal of Pharmaceutical Innovation (2023) Vol. 18, Iss. 4, pp. 1745-1763
Open Access | Times Cited: 7
Cost-Related Non-Adherence to Prescribed Medicines: What Are Physicians’ Moral Duties?
Narcyz Ghinea, Katrina Hutchison, Mianna Lotz, et al.
The American Journal of Bioethics (2024), pp. 1-12
Open Access | Times Cited: 2
The quality of medical products for cardiovascular diseases: a gap in global cardiac care
Ngan Thi, Khonsavath Bellingham, Paul N. Newton, et al.
BMJ Global Health (2021) Vol. 6, Iss. 9, pp. e006523-e006523
Open Access | Times Cited: 14
Tackling the global impact of substandard and falsified and unregistered/unlicensed anti-tuberculosis medicines
Tamara Akpobolokemi, Rocío T. Martínez-Nuñez, Bahijja Tolulope Raimi‐Abraham
The Journal of Medicine Access (2022) Vol. 6
Open Access | Times Cited: 9
I (Don’t) want to consume counterfeit medicines: exploratory study on the antecedents of consumer attitudes toward counterfeit medicines
Sylvester Senyo Ofori-Parku, Sung Eun Park
BMC Public Health (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 9
Substandard and falsified medical product recalls in Zambia from 2018 to 2021 and implications on the quality surveillance systems
Billy Chabalenge, Elimas Jere, Namuchindo Nanyangwe, et al.
The Journal of Medicine Access (2022) Vol. 6
Open Access | Times Cited: 9
Page 1 - Next Page

Scroll to top